We are live on ! Find out more
MCM

Marathon Capital Management Portfolio holdings

AUM $494M
1-Year Est. Return 42.6%
This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+42.6%
3 Year Est. Return
+70.91%
5 Year Est. Return
+55.81%
10 Year Est. Return
+429.8%
AUM
$419M
AUM Growth
+$21.2M
Cap. Flow
-$11.3M
Cap. Flow %
-2.7%
Top 10 Hldgs %
45.89%
Holding
166
New
13
Increased
44
Reduced
49
Closed
12

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$4.43M
2
RIG icon
Transocean
RIG
+$3.3M
3
CVX icon
Chevron
CVX
+$2.65M
4
NPKI
NPK International
NPKI
+$1.72M
5
SYM icon
Symbotic
SYM
+$1.71M

Sector Composition

Rank Sector Weight
1 Financials 33.19%
2 Technology 17.69%
3 Industrials 13.06%
4 Healthcare 11.44%
5 Energy 8.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TROW icon
1
T. Rowe Price
TROW
$25B
$105M 25.1%
862,917
-5,875
-0.7% -$656K
AZN icon
2
AstraZeneca
AZN
$263B
$11M 2.62%
81,044
+33,449
+70% +$4.43M
MSFT icon
3
Microsoft
MSFT
$2.84T
$10.3M 2.46%
24,519
-827
-3% -$335K
AAPL icon
4
Apple
AAPL
$4.89T
$10.1M 2.41%
58,937
+361
+0.6% +$65.6K
QCOM icon
5
Qualcomm
QCOM
$176B
$10.1M 2.41%
59,660
-305
-0.5% -$47.1K
CVX icon
6
Chevron
CVX
$388B
$9.94M 2.37%
63,032
+17,553
+39% +$2.65M
ALSN icon
7
Allison Transmission
ALSN
$10.1B
$9.72M 2.32%
119,717
-16,622
-12% -$1.12M
HLMN icon
8
Hillman Solutions
HLMN
$1.56B
$8.67M 2.07%
814,765
-4,460
-0.5% -$41.7K
ENPH icon
9
Enphase Energy
ENPH
$4.84B
$8.65M 2.06%
71,493
+207
+0.3% +$24.2K
MET icon
10
MetLife
MET
$61B
$8.64M 2.06%
116,596
-528
-0.5% -$36.8K
FANG icon
11
Diamondback Energy
FANG
$57.6B
$8.39M 2%
42,336
+1,646
+4% +$279K
IBM icon
12
IBM
IBM
$202B
$7.99M 1.91%
41,844
-1,120
-3% -$204K
GLW icon
13
Corning
GLW
$126B
$7.85M 1.87%
238,279
-1,114
-0.5% -$35.5K
FIS icon
14
Fidelity National Information Services
FIS
$21.5B
$6.99M 1.67%
94,288
-473
-0.5% -$30.8K
HDSN
15
Hudson Technologies
HDSN
$267M
$6.61M 1.58%
600,150
-7,950
-1% -$104K
CPA icon
16
Copa Holdings
CPA
$5.56B
$6.48M 1.55%
62,193
+1,920
+3% +$191K
BMY icon
17
Bristol-Myers Squibb
BMY
$127B
$6.23M 1.49%
114,880
+746
+0.7% +$38K
TTI icon
18
TETRA Technologies
TTI
$1.23B
$5.85M 1.4%
1,319,845
+24,400
+2% +$101K
INVE icon
19
Identive
INVE
$64.6M
$5.69M 1.36%
717,974
+1,650
+0.2% +$13.2K
DAL icon
20
Delta Air Lines
DAL
$55.9B
$5.54M 1.32%
115,703
+3,101
+3% +$128K
WTW icon
21
Willis Towers Watson
WTW
$27.9B
$5.51M 1.32%
20,053
-100
-0.5% -$26.3K
BRK.B icon
22
Berkshire Hathaway Class B
BRK.B
$1.07T
$5.28M 1.26%
12,566
-174
-1% -$68.4K
MRO
23
DELISTED
Marathon Oil Corporation
MRO
$5.04M 1.2%
177,713
+3,553
+2% +$85.7K
RIG icon
24
Transocean
RIG
$5.92B
$4.94M 1.18%
786,350
+604,850
+333% +$3.3M
ANIP icon
25
ANI Pharmaceuticals
ANIP
$1.77B
$4.92M 1.17%
71,170
+1,350
+2% +$81.5K

Similar funds

Marathon Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Marathon Capital Management held 166 positions worth $419M, up 5.3% from $398M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Marathon Capital Management's Q1 2024 filing shows 13 new, 44 increased, 49 reduced and 12 closed positions. Its largest new stake was NPK International: 263,150 shares worth $1.9M. The largest sale was PHYSICIANS REALTY TRUST, an estimated $6.06M.

By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 32% a quarter earlier, followed by Technology and Industrials.

  • Marathon Capital Management's largest Q1 2024 buy was NPK International: 263,150 shares worth $1.9M.
  • Marathon Capital Management added most to AstraZeneca in Q1 2024, an estimated $4.43M increase.
  • Marathon Capital Management's biggest Q1 2024 reduction was Helmerich & Payne, cutting an estimated $3.93M.
  • Marathon Capital Management fully exited PHYSICIANS REALTY TRUST in Q1 2024, selling an estimated $6.06M.
  • Marathon Capital Management's ten largest holdings make up 46% of its $419M portfolio in Q1 2024.
  • Marathon Capital Management opened 13 new positions and closed 12 in Q1 2024.
  • Marathon Capital Management's portfolio value rose 5.3% quarter-over-quarter to $419M.

Based on Marathon Capital Management's 13F filing for Q1 2024, filed 15 May 2024.